MyJournals Home  

RSS FeedsPrimum Non Nocere: When Nephrectomy Becomes a Selective Approach in Metastatic Renal Cell Carcinoma (European Urology Oncology)

 
 

20 march 2020 02:03:10

 
Primum Non Nocere: When Nephrectomy Becomes a Selective Approach in Metastatic Renal Cell Carcinoma (European Urology Oncology)
 




Primum non nocere: first do no harm is the first ethical principle of medicine. The CARMENA trial [1] raised the question of the value of nephrectomy in metastatic renal cell carcinoma (mRCC). By demonstrating that the overall survival (OS) of patients treated with sunitinib was not inferior than that of patients treated with nephrectomy and sunitinib, CARMENA answered the first part of the question. The second part would be to know how to treat the primary tumor in patients who are good responders to mRCC systemic therapies.


Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
19 viewsCategory: Oncology, Urology
 
Chromophobe Renal Cell Carcinoma Aggressiveness and Immuno-oncology Therapy: How to Distinguish the Good One from the Bad One (European Urology Oncology)
Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis (European Urology Oncology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn